Skip to main content
Erschienen in: Journal of Gastrointestinal Cancer 4/2021

15.01.2022 | Invited Reviews

Zebrafish Xenotransplantation Models for Studying Gene Function and Drug Treatment in Hepatocellular Carcinoma

verfasst von: Seniye Targen, Ozlen Konu

Erschienen in: Journal of Gastrointestinal Cancer | Ausgabe 4/2021

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Zebrafish is a promising model organism for human disease including hepatocellular cancer (HCC). Recently, zebrafish has emerged also as a host for xenograft studies of liver cancer cell lines and patient derived tumors of HCC. Zebrafish embryos enable drug screening and gene function studies of xenografted cells via ease of microinjection and visualization of tumor growth and metastasis.

Objectives

In this review, we aimed to overview zebrafish HCC and liver cancer xenotransplantation studies focusing on ‘gene functional analysis’ and ‘drug/chemical screening’.

Methods

Herein, a comprehensive literature search was performed for liver and HCC xenografts in zebrafish on PubMed using different key words and filters for molecular modifications or drug exposure.

Results

Our literature search revealed around 250 studies which were filtered and summarized in a table (Table 1) revealing comprehensive collection of experimental and technical details on microinjection, injected cell lines, molecular modifications of injected cells, types and doses of drug treatments as well as biological assessments.

Conclusion

This review provides a platform for HCC and liver xenografts and highlights studies performed to understand gene functionality and drug efficacy in vivo in zebrafish.
Literatur
1.
Zurück zum Zitat Fazio M, Ablain J, Chuan Y, Langenau DM, Zon LI. Zebrafish patient avatars in cancer biology and precision cancer therapy. Nat Rev Cancer. 2020. Fazio M, Ablain J, Chuan Y, Langenau DM, Zon LI. Zebrafish patient avatars in cancer biology and precision cancer therapy. Nat Rev Cancer. 2020.
2.
Zurück zum Zitat Drabsch Y, Snaar-Jagalska BE, Ten Dijke P. Fish tales: the use of zebrafish xenograft human cancer cell models. Histol Histopathol. 2017. Drabsch Y, Snaar-Jagalska BE, Ten Dijke P. Fish tales: the use of zebrafish xenograft human cancer cell models. Histol Histopathol. 2017.
3.
Zurück zum Zitat Targen S, Kaya T, Ender Avci M, Gunes D, Keskus AG, Konu O. ZenoFishDb v1.1: a database for xenotransplantation studies in zebrafish. Zebrafish. 2020;17. Targen S, Kaya T, Ender Avci M, Gunes D, Keskus AG, Konu O. ZenoFishDb v1.1: a database for xenotransplantation studies in zebrafish. Zebrafish. 2020;17.
4.
Zurück zum Zitat Tonon F, Farra R, Zennaro C, Pozzato G, Truong N, Parisi S, Rizzolio F, Grassi M, Scaggiante B, Zanconati F, Bonazza D. Xenograft zebrafish models for the development of novel anti-hepatocellular carcinoma molecules. Pharmaceuticals. 2021;14(8):803. https://doi.org/10.3390/ph14080803. Tonon F, Farra R, Zennaro C, Pozzato G, Truong N, Parisi S, Rizzolio F, Grassi M, Scaggiante B, Zanconati F, Bonazza D. Xenograft zebrafish models for the development of novel anti-hepatocellular carcinoma molecules. Pharmaceuticals. 2021;14(8):803. https://​doi.​org/​10.​3390/​ph14080803.
5.
Zurück zum Zitat Tonon F, Zennaro C, Dapas B, Carraro M, Mariotti M, Grassi G. Rapid and cost-effective xenograft hepatocellular carcinoma model in zebrafish for drug testing. Int J Pharm. 2016;515. Tonon F, Zennaro C, Dapas B, Carraro M, Mariotti M, Grassi G. Rapid and cost-effective xenograft hepatocellular carcinoma model in zebrafish for drug testing. Int J Pharm. 2016;515.
6.
Zurück zum Zitat Karkampouna S, van der Helm D, Gray PC, Chen L, Klima I, Grosjean J, et al. CRIPTO promotes an aggressive tumour phenotype and resistance to treatment in hepatocellular carcinoma. J Pathol. 2018. Karkampouna S, van der Helm D, Gray PC, Chen L, Klima I, Grosjean J, et al. CRIPTO promotes an aggressive tumour phenotype and resistance to treatment in hepatocellular carcinoma. J Pathol. 2018.
7.
Zurück zum Zitat Li Y, Wu Q, Yu G, Li L, Zhao X, Huang X, et al. Polypyridyl ruthenium(II) complex-induced mitochondrial membrane potential dissipation activates DNA damage-mediated apoptosis to inhibit liver cancer. Eur J Med Chem. 2019;164. Li Y, Wu Q, Yu G, Li L, Zhao X, Huang X, et al. Polypyridyl ruthenium(II) complex-induced mitochondrial membrane potential dissipation activates DNA damage-mediated apoptosis to inhibit liver cancer. Eur J Med Chem. 2019;164.
8.
Zurück zum Zitat Bartucci M, Hussein MS, Huselid E, Flaherty K, Patrizii M, Laddha SV, et al. Synthesis and characterization of novel BMI1 inhibitors targeting cellular self-renewal in hepatocellular carcinoma. Target Oncol. 2017;12. Bartucci M, Hussein MS, Huselid E, Flaherty K, Patrizii M, Laddha SV, et al. Synthesis and characterization of novel BMI1 inhibitors targeting cellular self-renewal in hepatocellular carcinoma. Target Oncol. 2017;12.
9.
Zurück zum Zitat Wu L, Chen P, Ying J, Zhang Q, Liu F, Lv B, et al. MAT2B mediates invasion and metastasis by regulating EGFR signaling pathway in hepatocellular carcinoma. Clin Exp Med. 2019;19. Wu L, Chen P, Ying J, Zhang Q, Liu F, Lv B, et al. MAT2B mediates invasion and metastasis by regulating EGFR signaling pathway in hepatocellular carcinoma. Clin Exp Med. 2019;19.
10.
Zurück zum Zitat Nakayama J, Lu JW, Makinoshima H, Gong Z. A novel zebrafish model of metastasis identifies the HSD11b1 inhibitor adrenosterone as a suppressor of epithelial-mesenchymal transition and metastatic dissemination. Mol Cancer Res. 2020;18. Nakayama J, Lu JW, Makinoshima H, Gong Z. A novel zebrafish model of metastasis identifies the HSD11b1 inhibitor adrenosterone as a suppressor of epithelial-mesenchymal transition and metastatic dissemination. Mol Cancer Res. 2020;18.
11.
Zurück zum Zitat Yang J, Pei H, Luo H, Fu A, Yang H, Hu J, et al. Non-toxic dose of liposomal honokiol suppresses metastasis of hepatocellular carcinoma through destabilizing EGFR and inhibiting the downstream pathways. Oncotarget. 2017;8. Yang J, Pei H, Luo H, Fu A, Yang H, Hu J, et al. Non-toxic dose of liposomal honokiol suppresses metastasis of hepatocellular carcinoma through destabilizing EGFR and inhibiting the downstream pathways. Oncotarget. 2017;8.
12.
Zurück zum Zitat Poté N, Cros J, Laouirem S, Raffenne J, Negrão M, Albuquerque M, et al. The histone acetyltransferase hMOF promotes vascular invasion in hepatocellular carcinoma. Liver Int. 2020;40. Poté N, Cros J, Laouirem S, Raffenne J, Negrão M, Albuquerque M, et al. The histone acetyltransferase hMOF promotes vascular invasion in hepatocellular carcinoma. Liver Int. 2020;40.
13.
Zurück zum Zitat Sie ZL, Li RY, Sampurna BP, Hsu PJ, Liu SC, Wang HD, et al. WNK1 kinase stimulates angiogenesis to promote tumor growth and metastasis. Cancers. 2020;12. Sie ZL, Li RY, Sampurna BP, Hsu PJ, Liu SC, Wang HD, et al. WNK1 kinase stimulates angiogenesis to promote tumor growth and metastasis. Cancers. 2020;12.
14.
Zurück zum Zitat Avci ME, Keskus AG, Targen S, Isilak ME, Ozturk M, Atalay RC, et al. Development of a novel zebrafish xenograft model in ache mutants using liver cancer cell lines. Sci Rep. Springer US; 2018;8:1570. Avci ME, Keskus AG, Targen S, Isilak ME, Ozturk M, Atalay RC, et al. Development of a novel zebrafish xenograft model in ache mutants using liver cancer cell lines. Sci Rep. Springer US; 2018;8:1570.
15.
Zurück zum Zitat Khan N, Mahajan NK, Sinha P, Jayandharan GR. An efficient method to generate xenograft tumor models of acute myeloid leukemia and hepatocellular carcinoma in adult zebrafish. Blood Cells Mol Dis. 2019. Khan N, Mahajan NK, Sinha P, Jayandharan GR. An efficient method to generate xenograft tumor models of acute myeloid leukemia and hepatocellular carcinoma in adult zebrafish. Blood Cells Mol Dis. 2019.
16.
Zurück zum Zitat Kim EA, Lee JH, Heo SJ, Jeon YJ. Saringosterol acetate isolated from Hizikia fusiforme, an edible brown alga, suppressed hepatocellular carcinoma growth and metastasis in a zebrafish xenograft model. Chem Biol Interact. 2021;335. Kim EA, Lee JH, Heo SJ, Jeon YJ. Saringosterol acetate isolated from Hizikia fusiforme, an edible brown alga, suppressed hepatocellular carcinoma growth and metastasis in a zebrafish xenograft model. Chem Biol Interact. 2021;335.
17.
Zurück zum Zitat Tu H-C, Hsiao Y-C, Yang W-Y, Tsai S-L, Lin H-K, Liao C-Y, et al. Up-regulation of golgi α-mannosidase IA and down-regulation of golgi α-mannosidase IC activates unfolded protein response during hepatocarcinogenesis. Hepatol Commun. 2017;1. Tu H-C, Hsiao Y-C, Yang W-Y, Tsai S-L, Lin H-K, Liao C-Y, et al. Up-regulation of golgi α-mannosidase IA and down-regulation of golgi α-mannosidase IC activates unfolded protein response during hepatocarcinogenesis. Hepatol Commun. 2017;1.
18.
Zurück zum Zitat Iscan E, Ekin U, Yildiz G, Oz O, Keles U, Suner A, et al. TAp73β can promote hepatocellular carcinoma dedifferentiation. Cancers. 2021;13. Iscan E, Ekin U, Yildiz G, Oz O, Keles U, Suner A, et al. TAp73β can promote hepatocellular carcinoma dedifferentiation. Cancers. 2021;13.
19.
Zurück zum Zitat Topel H, Bagirsakci E, Comez D, Bagci G, Cakan-Akdogan G, Atabey N. lncRNA HOTAIR overexpression induced downregulation of c-Met signaling promotes hybrid epithelial/mesenchymal phenotype in hepatocellular carcinoma cells. Cell Communication and Signaling. 2020;18. Topel H, Bagirsakci E, Comez D, Bagci G, Cakan-Akdogan G, Atabey N. lncRNA HOTAIR overexpression induced downregulation of c-Met signaling promotes hybrid epithelial/mesenchymal phenotype in hepatocellular carcinoma cells. Cell Communication and Signaling. 2020;18.
20.
Zurück zum Zitat Akbari S, Kunter I, Azbazdar Y, Ozhan G, Atabey N, Firtina Karagonlar Z, et al. LGR5/R-Spo1/Wnt3a axis promotes stemness and aggressive phenotype in hepatoblast-like hepatocellular carcinoma cell lines. Cell Signal. 2021;82. Akbari S, Kunter I, Azbazdar Y, Ozhan G, Atabey N, Firtina Karagonlar Z, et al. LGR5/R-Spo1/Wnt3a axis promotes stemness and aggressive phenotype in hepatoblast-like hepatocellular carcinoma cell lines. Cell Signal. 2021;82.
21.
Zurück zum Zitat Huang D, Yang B, Yao Y, Liao M, Zhang Y, Zeng Y, et al. Autophagic inhibition of caveolin-1 by compound Phyllanthus urinaria L. activates ubiquitination and proteasome degradation of β-catenin to suppress metastasis of hepatitis B-associated hepatocellular carcinoma. Front Pharmacol. 2021;12. Huang D, Yang B, Yao Y, Liao M, Zhang Y, Zeng Y, et al. Autophagic inhibition of caveolin-1 by compound Phyllanthus urinaria L. activates ubiquitination and proteasome degradation of β-catenin to suppress metastasis of hepatitis B-associated hepatocellular carcinoma. Front Pharmacol. 2021;12.
22.
Zurück zum Zitat Chou YT, Chen LY, Tsai SL, Tu HC, Lu JW, Ciou SC, et al. Ribose-5-phosphate isomerase A overexpression promotes liver cancer development in transgenic zebrafish via activation of ERK and β-catenin pathways. Carcinogenesis. 2019;40. Chou YT, Chen LY, Tsai SL, Tu HC, Lu JW, Ciou SC, et al. Ribose-5-phosphate isomerase A overexpression promotes liver cancer development in transgenic zebrafish via activation of ERK and β-catenin pathways. Carcinogenesis. 2019;40.
23.
Zurück zum Zitat Liu JS, Huo CY, Cao HH, Fan CL, Hu JY, Deng LJ, et al. Aloperine induces apoptosis and G2/M cell cycle arrest in hepatocellular carcinoma cells through the PI3K/Akt signaling pathway. Phytomedicine. 2019;61. Liu JS, Huo CY, Cao HH, Fan CL, Hu JY, Deng LJ, et al. Aloperine induces apoptosis and G2/M cell cycle arrest in hepatocellular carcinoma cells through the PI3K/Akt signaling pathway. Phytomedicine. 2019;61.
24.
Zurück zum Zitat Wei PL, Huang CY, Chang YJ. Propyl gallate inhibits hepatocellular carcinoma cell growth through the induction of ROS and the activation of autophagy. PLoS ONE. 2019;14. Wei PL, Huang CY, Chang YJ. Propyl gallate inhibits hepatocellular carcinoma cell growth through the induction of ROS and the activation of autophagy. PLoS ONE. 2019;14.
25.
Zurück zum Zitat Zhao LJ, Zhao HY, Wei XL, Guo FF, Wei JY, Wang HJ, et al. The lipid homeostasis regulation study of arenobufagin in zebrafish HepG2 xenograft model and HepG2 cells using integrated lipidomics-proteomics approach. J Ethnopharmacol. 2020;260. Zhao LJ, Zhao HY, Wei XL, Guo FF, Wei JY, Wang HJ, et al. The lipid homeostasis regulation study of arenobufagin in zebrafish HepG2 xenograft model and HepG2 cells using integrated lipidomics-proteomics approach. J Ethnopharmacol. 2020;260.
26.
Zurück zum Zitat Gao J, Yin Z, Wu Z, Sheng Z, Ma C, Chen R, et al. Probing synergistic targets by natural compounds for hepatocellular carcinoma. Front Cell Dev Biol. 2021;9. Gao J, Yin Z, Wu Z, Sheng Z, Ma C, Chen R, et al. Probing synergistic targets by natural compounds for hepatocellular carcinoma. Front Cell Dev Biol. 2021;9.
27.
Zurück zum Zitat Xu J, Yan B, Zhang L, Zhou L, Zhang J, Yu W, et al. Theabrownin induces apoptosis and tumor inhibition of hepatocellular carcinoma HUH7 cells through ask1-jnk-c-jun pathway. OncoTargets and Therapy. 2020;13. Xu J, Yan B, Zhang L, Zhou L, Zhang J, Yu W, et al. Theabrownin induces apoptosis and tumor inhibition of hepatocellular carcinoma HUH7 cells through ask1-jnk-c-jun pathway. OncoTargets and Therapy. 2020;13.
28.
Zurück zum Zitat Meehan TF, Conte N, Goldstein T, Inghirami G, Murakami MA, Brabetz S, et al. PDX-MI: minimal information for patient-derived tumor xenograft models. Cancer Res. 2017;77. Meehan TF, Conte N, Goldstein T, Inghirami G, Murakami MA, Brabetz S, et al. PDX-MI: minimal information for patient-derived tumor xenograft models. Cancer Res. 2017;77.
29.
Zurück zum Zitat Conte N, Mason JC, Halmagyi C, Neuhauser S, Mosaku A, Yordanova G, et al. PDX Finder: a portal for patient-derived tumor xenograft model discovery. Nucleic Acids Res. 2019;47. Conte N, Mason JC, Halmagyi C, Neuhauser S, Mosaku A, Yordanova G, et al. PDX Finder: a portal for patient-derived tumor xenograft model discovery. Nucleic Acids Res. 2019;47.
30.
Zurück zum Zitat He S, Hu B, Li C, Lin P, Tang WG, Sun YF, et al. PDXliver: a database of liver cancer patient derived xenograft mouse models. BMC Cancer. 2018; He S, Hu B, Li C, Lin P, Tang WG, Sun YF, et al. PDXliver: a database of liver cancer patient derived xenograft mouse models. BMC Cancer. 2018;
31.
Zurück zum Zitat Lin HS, Huang YL, Wang YR, Hsiao E, Hsu TA, Shiao HY, et al. Identification of novel anti-liver cancer small molecules with better therapeutic index than sorafenib via zebrafish drug screening platform. Cancers. 2019; Lin HS, Huang YL, Wang YR, Hsiao E, Hsu TA, Shiao HY, et al. Identification of novel anti-liver cancer small molecules with better therapeutic index than sorafenib via zebrafish drug screening platform. Cancers. 2019;
32.
Zurück zum Zitat Usai A, Di Franco G, Colucci P, Pollina LE, Vasile E, Funel N, et al. A model of a zebrafish avatar for co-clinical trials. Cancers. 2020;12. Usai A, Di Franco G, Colucci P, Pollina LE, Vasile E, Funel N, et al. A model of a zebrafish avatar for co-clinical trials. Cancers. 2020;12.
33.
Zurück zum Zitat Di Franco G, Usai A, Funel N, Palmeri M, Rosamaria Montesanti IE, Bianchini M, et al. Use of zebrafish embryos as avatar of patients with pancreatic cancer: a new xenotransplantation model towards personalized medicine. World J Gastroenterol. 2020;26. Di Franco G, Usai A, Funel N, Palmeri M, Rosamaria Montesanti IE, Bianchini M, et al. Use of zebrafish embryos as avatar of patients with pancreatic cancer: a new xenotransplantation model towards personalized medicine. World J Gastroenterol. 2020;26.
34.
Zurück zum Zitat Ikonomopoulou MP, Fernandez-Rojo MA, Pineda SS, Cabezas-Sainz P, Winnen B, Morales RAV, et al. Gomesin inhibits melanoma growth by manipulating key signaling cascades that control cell death and proliferation. Sci Rep. 2018;8. Ikonomopoulou MP, Fernandez-Rojo MA, Pineda SS, Cabezas-Sainz P, Winnen B, Morales RAV, et al. Gomesin inhibits melanoma growth by manipulating key signaling cascades that control cell death and proliferation. Sci Rep. 2018;8.
35.
Zurück zum Zitat Yuan Y, Zhang Y, Yao S, Shi H, Huang X, Li Y, et al. The translation initiation factor eIF3i up-regulates vascular endothelial growth factor A, accelerates cell proliferation, and promotes angiogenesis in embryonic development and tumorigenesis. J Biol Chem. 2014;289. Yuan Y, Zhang Y, Yao S, Shi H, Huang X, Li Y, et al. The translation initiation factor eIF3i up-regulates vascular endothelial growth factor A, accelerates cell proliferation, and promotes angiogenesis in embryonic development and tumorigenesis. J Biol Chem. 2014;289.
36.
Zurück zum Zitat Zhang H, Song Y, Li L, Zhang SY, Wu Q, Mei WJ, et al. Phenanthroimidazole derivatives act as potent inducer of autophagy by activating DNA damage pathway. Bioinorg Chem. 2019;88. Zhang H, Song Y, Li L, Zhang SY, Wu Q, Mei WJ, et al. Phenanthroimidazole derivatives act as potent inducer of autophagy by activating DNA damage pathway. Bioinorg Chem. 2019;88.
37.
Zurück zum Zitat Dawood M, Hegazy MEF, Elbadawi M, Fleischer E, Klinger A, Bringmann G, et al. Vitamin K3 chloro derivative (VKT-2) inhibits HDAC6, activates autophagy and apoptosis, and inhibits aggresome formation in hepatocellular carcinoma cells. Biochem Pharmacol. 2020;180. Dawood M, Hegazy MEF, Elbadawi M, Fleischer E, Klinger A, Bringmann G, et al. Vitamin K3 chloro derivative (VKT-2) inhibits HDAC6, activates autophagy and apoptosis, and inhibits aggresome formation in hepatocellular carcinoma cells. Biochem Pharmacol. 2020;180.
38.
Zurück zum Zitat Deng LJ, Lei YH, Quan JY, Li BJ, Zhang DM, Tian HY, et al. 1β–OH–arenobufagin induces mitochondrial apoptosis in hepatocellular carcinoma through the suppression of mTOR signaling pathway. J Ethnopharmacol. 2021;266. Deng LJ, Lei YH, Quan JY, Li BJ, Zhang DM, Tian HY, et al. 1β–OH–arenobufagin induces mitochondrial apoptosis in hepatocellular carcinoma through the suppression of mTOR signaling pathway. J Ethnopharmacol. 2021;266.
39.
Zurück zum Zitat Huang CY, Chang YJ, Wei PL, Hung CS, Wang W. Methyl gallate, gallic acid-derived compound, inhibit cell proliferation through increasing ROS production and apoptosis in hepatocellular carcinoma cells. PLoS ONE. 2021;16. Huang CY, Chang YJ, Wei PL, Hung CS, Wang W. Methyl gallate, gallic acid-derived compound, inhibit cell proliferation through increasing ROS production and apoptosis in hepatocellular carcinoma cells. PLoS ONE. 2021;16.
40.
Zurück zum Zitat Chen Y, Yang W, Chen Q, Liu Q, Liu J, Zhang Y, et al. Prediction of hepatocellular carcinoma risk in patients with chronic liver disease from dynamic modular networks. J Transl Med. 2021;19. Chen Y, Yang W, Chen Q, Liu Q, Liu J, Zhang Y, et al. Prediction of hepatocellular carcinoma risk in patients with chronic liver disease from dynamic modular networks. J Transl Med. 2021;19.
41.
Zurück zum Zitat Zhang C, Li Q, Qin G, Zhang Y, Li C, Han L, et al. Anti-angiogenesis and anti-metastasis effects of polyphyllin VII on hepatocellular carcinoma cells in vitro and in vivo. Chinese Medicine (United Kingdom). 2021;16. Zhang C, Li Q, Qin G, Zhang Y, Li C, Han L, et al. Anti-angiogenesis and anti-metastasis effects of polyphyllin VII on hepatocellular carcinoma cells in vitro and in vivo. Chinese Medicine (United Kingdom). 2021;16.
42.
Zurück zum Zitat Hou Y, Chu M, Du FF, Lei JY, Chen Y, Zhu RY, et al. Recombinant disintegrin domain of ADAM15 inhibits the proliferation and migration of Bel-7402 cells. Biochem Biophys Res Commun. 2013;435. Hou Y, Chu M, Du FF, Lei JY, Chen Y, Zhu RY, et al. Recombinant disintegrin domain of ADAM15 inhibits the proliferation and migration of Bel-7402 cells. Biochem Biophys Res Commun. 2013;435.
43.
Zurück zum Zitat Zhu XY, Guo DW, Lao QC, Xu YQ, Meng ZK, Xia B, et al. Sensitization and synergistic anti-cancer effects of furanodiene identified in zebrafish models. Sci Rep. 2019;9. Zhu XY, Guo DW, Lao QC, Xu YQ, Meng ZK, Xia B, et al. Sensitization and synergistic anti-cancer effects of furanodiene identified in zebrafish models. Sci Rep. 2019;9.
44.
Zurück zum Zitat Gunes A, Bagirsakci E, Iscan E, Cakan-Akdogan G, Aykutlu U, Senturk S, et al. Thioredoxin interacting protein promotes invasion in hepatocellular carcinoma. Oncotarget 2018;9. Gunes A, Bagirsakci E, Iscan E, Cakan-Akdogan G, Aykutlu U, Senturk S, et al. Thioredoxin interacting protein promotes invasion in hepatocellular carcinoma. Oncotarget 2018;9.
45.
Zurück zum Zitat Tseng CH, Chen YR, Tzeng CC, Liu W, Chou CK, Chiu CC, et al. Discovery of indeno[1,2-b]quinoxaline derivatives as potential anticancer agents. Euro J Medicinal Chem. 2016;108. Tseng CH, Chen YR, Tzeng CC, Liu W, Chou CK, Chiu CC, et al. Discovery of indeno[1,2-b]quinoxaline derivatives as potential anticancer agents. Euro J Medicinal Chem. 2016;108.
46.
Zurück zum Zitat Tian L, Xie K, Sheng D, Wan X, Zhu G. Antiangiogenic effects of oridonin. BMC Complemen Altern Med. 2017;17. Tian L, Xie K, Sheng D, Wan X, Zhu G. Antiangiogenic effects of oridonin. BMC Complemen Altern Med. 2017;17.
47.
Zurück zum Zitat Chang WT, Liu W, Chiu YH, Chen BH, Chuang SC, Chen YC, et al. A 4-phenoxyphenol derivative exerts inhibitory effects on human hepatocellular carcinoma cells through regulating autophagy and apoptosis accompanied by downregulating α-tubulin expression. Molecules 2017;22. Chang WT, Liu W, Chiu YH, Chen BH, Chuang SC, Chen YC, et al. A 4-phenoxyphenol derivative exerts inhibitory effects on human hepatocellular carcinoma cells through regulating autophagy and apoptosis accompanied by downregulating α-tubulin expression. Molecules 2017;22. 
Metadaten
Titel
Zebrafish Xenotransplantation Models for Studying Gene Function and Drug Treatment in Hepatocellular Carcinoma
verfasst von
Seniye Targen
Ozlen Konu
Publikationsdatum
15.01.2022
Verlag
Springer US
Erschienen in
Journal of Gastrointestinal Cancer / Ausgabe 4/2021
Print ISSN: 1941-6628
Elektronische ISSN: 1941-6636
DOI
https://doi.org/10.1007/s12029-021-00782-z

Weitere Artikel der Ausgabe 4/2021

Journal of Gastrointestinal Cancer 4/2021 Zur Ausgabe

Viel pflanzliche Nahrung, seltener Prostata-Ca.-Progression

12.05.2024 Prostatakarzinom Nachrichten

Ein hoher Anteil pflanzlicher Nahrung trägt möglicherweise dazu bei, das Progressionsrisiko von Männern mit Prostatakarzinomen zu senken. In einer US-Studie war das Risiko bei ausgeprägter pflanzlicher Ernährung in etwa halbiert.

Alter verschlechtert Prognose bei Endometriumkarzinom

11.05.2024 Endometriumkarzinom Nachrichten

Ein höheres Alter bei der Diagnose eines Endometriumkarzinoms ist mit aggressiveren Tumorcharakteristika assoziiert, scheint aber auch unabhängig von bekannten Risikofaktoren die Prognose der Erkrankung zu verschlimmern.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Erhöhte Mortalität bei postpartalem Brustkrebs

07.05.2024 Mammakarzinom Nachrichten

Auch für Trägerinnen von BRCA-Varianten gilt: Erkranken sie fünf bis zehn Jahre nach der letzten Schwangerschaft an Brustkrebs, ist das Sterberisiko besonders hoch.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.